Cargando…
Are the Cardiorenal Benefits of SGLT2 Inhibitors Due to Inhibition of the Sympathetic Nervous System?
[Figure: see text]
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046535/ https://www.ncbi.nlm.nih.gov/pubmed/32142070 http://dx.doi.org/10.1016/j.jacbts.2020.01.011 |
| _version_ | 1783501966098300928 |
|---|---|
| author | Verma, Subodh |
| author_facet | Verma, Subodh |
| author_sort | Verma, Subodh |
| collection | PubMed |
| description | [Figure: see text] |
| format | Online Article Text |
| id | pubmed-7046535 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70465352020-03-05 Are the Cardiorenal Benefits of SGLT2 Inhibitors Due to Inhibition of the Sympathetic Nervous System? Verma, Subodh JACC Basic Transl Sci Editorial Comment [Figure: see text] Elsevier 2020-02-24 /pmc/articles/PMC7046535/ /pubmed/32142070 http://dx.doi.org/10.1016/j.jacbts.2020.01.011 Text en © 2020 The Author http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Editorial Comment Verma, Subodh Are the Cardiorenal Benefits of SGLT2 Inhibitors Due to Inhibition of the Sympathetic Nervous System? |
| title | Are the Cardiorenal Benefits of SGLT2 Inhibitors Due to Inhibition of the Sympathetic Nervous System? |
| title_full | Are the Cardiorenal Benefits of SGLT2 Inhibitors Due to Inhibition of the Sympathetic Nervous System? |
| title_fullStr | Are the Cardiorenal Benefits of SGLT2 Inhibitors Due to Inhibition of the Sympathetic Nervous System? |
| title_full_unstemmed | Are the Cardiorenal Benefits of SGLT2 Inhibitors Due to Inhibition of the Sympathetic Nervous System? |
| title_short | Are the Cardiorenal Benefits of SGLT2 Inhibitors Due to Inhibition of the Sympathetic Nervous System? |
| title_sort | are the cardiorenal benefits of sglt2 inhibitors due to inhibition of the sympathetic nervous system? |
| topic | Editorial Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046535/ https://www.ncbi.nlm.nih.gov/pubmed/32142070 http://dx.doi.org/10.1016/j.jacbts.2020.01.011 |
| work_keys_str_mv | AT vermasubodh arethecardiorenalbenefitsofsglt2inhibitorsduetoinhibitionofthesympatheticnervoussystem |